Journal of Liposome Research
Volume 32, 2022 - Issue 4
Articles
Development of asolectin-based liposomal formulation for controlled and targeted delivery of erlotinib as a model drug for EGFR monotherapy
, 
, , , &
Amrendra Tiwaria Pharmaceutics and Pharmacokinetics Division, CSIR-Central Drug Research Institute, Lucknow, Indiahttps://orcid.org/0000-0003-4477-3788
https://orcid.org/0000-0003-4477-3788, , Pankaj K Singha Pharmaceutics and Pharmacokinetics Division, CSIR-Central Drug Research Institute, Lucknow, India;b Department of Pharmaceutics, NIPER Hyderabad, Hyderabad, Indiahttps://orcid.org/0000-0001-8462-2170
https://orcid.org/0000-0001-8462-2170, & 